comparison of Injectable platelet rich fibrin and steroids in oral lichen planus
- Conditions
- Health Condition 1: D899- Disorder involving the immune mechanism, unspecifiedHealth Condition 2: K137- Other and unspecified lesions of oral mucosa
- Registration Number
- CTRI/2023/11/060372
- Lead Sponsor
- PGIDS Rohtak
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1)Clinically symptomatic and histologically proven cases of oral lichen planus in accordance to WHO criteria.
2)Patient who give written consent to participate in the study
)Patient under the age of 18 years.
2)Histopathological signs of moderate to severe dysplasia.
3)Patients with genital or cutaneous involvement.
4)History of topical or systemic corticosteroids therapy within one month prior to recruitment.
5)Allergic or contraindication to administration of injectable corticosteroids.
6)Patients with Hb levels <9 gm/dl and platelet count < 1 lakh/dl.
7)Patients with known hematological disease, chronic liver disease and psychiatric disorders.
8)Smokers or chewable tobacco users.
9)Patients with pregnancy or lactating mothers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method